Sent on behalf of Supply Chain Governance Committee:

Physician, clinical and administrative leadership,

The Supply Chain Governance Committee has voted to lift the moratorium on requests for new products and vendors. The moratorium was put into place on Dec. 1, 2022 to help control rapidly escalating supply expense during a time of extreme inflation.

Though we are lifting the moratorium on the addition of new products, we are mindful that our organization continues to face significant financial headwinds. However, a core HonorHealth value is innovation, and we want our providers to have access to innovative technologies that drive improved value in care delivery. There will be a new level of discipline around determining if a new technology is needed at our network.

We request that physicians and perioperative leaders, in combination with service line and supply chain leaders, exercise a disciplined and thorough approach in evaluating new products.

Thank you for operating in a mindset of stewardship as we continue to navigate through this challenging financial environment.

HonorHealth’s Supply Chain Governance Committee consists of the following leaders:

Derek Hampshire, VP, finance                                  Kim Post, RN, EVP, COO

Riana Kielly, RN, COO, VP, periop services             Lisa Replogle, SVP, CFO

Kevin Ridderhoff, Pharm.D., senior director,           Ryan Kirane, VP, supply chain services
pharmacy – ambulatory

Matt Morgan, COO, Deer Valley Med Center         Susan Vance, VP, HonorHealth Medical Group

Frank Moussa, MD, medical director,                      John Neil, MD, EVP, chief physician executive,
surgery and supply chain                                         network strategy officer

Kathi Zarubi, RN, SVP, chief nursing executive      Nina Shah, MD, VP, chief medical officer

David Price, SVP, ambulatory operations               Eric Zuhlke, RN, VP, ambulatory integration

Bina Patel, Pharm.D., AVP, acute care pharmacy